Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

PHOTOCURE ASA (PHO)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Photocure ASA : Mandatory notification of trade

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2013 | 11:02am CET
Photocure ASA - Selling price of shares

Reference is made to the statement dated 15.03.2013. The payment has been determined based on a selling price of NOK 40.2584 per share.

After exercising options, Grete Hogstad holds 8 750 unexercised options in the Company, corresponding to 8 750 shares at the strike price of NOK 20.30. In addition she holds; 7
200 unexercised options, corresponding to 7 200 shares at the strike price of NOK 32.00;
23 400 unexercised options, corresponding to 23 400 shares at the strike price of NOK
44.00; and 17 250 unexercised options, corresponding to 17 250 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 10 500 shares in the Company.
After exercising options, Gry Stensrud holds 6 250 unexercised options in the Company, corresponding to 6 250 shares at the strike price of 20.30. In addition she holds; 19 050 unexercised options, corresponding to 19 050 shares at the strike price of NOK 44.00; and 22 500 unexercised options, corresponding to 22 500 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 6 shares in the Company.

For further information, please contact: Photocure

CFO Erik Dahl
Tel: +47 450 55 000, Email: [email protected]

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PHOTOCURE ASA
11/09 PHOTOCURE ASA : Clinical and cost impact analysis shows beneficial impact of rep..
11/08 PHOTOCURE ASA : Results for the third quarter of 2017
11/03 PHOTOCURE ASA : U.S. CMS improves reimbursement for Blue Light Cystoscopy with C..
11/02 PHOTOCURE ASA : U.S. CMS improves reimbursement for Blue Light Cystoscopy with C..
10/31 PHOTOCURE ASA : Presentation of the third quarter 2017 results
10/23 PHOTOCURE ASA : BLC(TM) with Cysview®/Hexvix® real World Data presented at the S..
10/18 PHOTOCURE ASA : FDA grants priority review for Cysview® supplemental New Drug Ap..
09/12 PHOTOCURE : Financial calendar
08/23 PHOTOCURE ASA : Results for second quarter and first half year of 2017
08/21 PHOTOCURE : Pengana/HunterHall- reduction in holding- Photocure ASA
More news
News from SeekingAlpha
08/23 Photocure ASA 2017 Q2 - Results - Earnings Call Slides
05/24 PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow
05/24 PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow
Financials ( NOK)
Sales 2017 150 M
EBIT 2017 -45,0 M
Net income 2017 -36,3 M
Finance 2017 107 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 3,12x
EV / Sales 2018 2,15x
Capitalization 573 M
Chart PHOTOCURE ASA
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Technical analysis trends PHOTOCURE ASA
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 35,0  NOK
Spread / Average Target 32%
EPS Revisions
Managers
NameTitle
Kjetil Hestdal President, Chief Executive Officer & Media Contact
Jan Hendrik Egberts Chairman
Gry Stensrud VP-Technical Development & Operations
Erik Dahl Chief Financial Officer
Inger Ferner Heglund Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
PHOTOCURE ASA-36.67%70
JOHNSON & JOHNSON19.17%368 832
NOVARTIS12.82%222 846
ROCHE HOLDING LTD.6.15%216 979
PFIZER9.08%211 188
MERCK AND COMPANY-7.64%148 286